No Picture
Trading Ideas

Intel’s Bullish Sales Forecasts Powered by Data Center Revival

(Bloomberg) — Intel Corp. gave bullish quarterly and full-year revenue forecasts, suggesting personal-computer demand remains strong and purchasing by data center owners has come surging back. The shares jumped as much as 7.2% in late trading.Revenue in the current period will be roughly $19 billion, and profit will be about $1.23 a share, excluding certain items, Intel also said. That compares with average analysts’ estimates of $17.2 billion and $1.04 a share.Sales in 2020 will be about $73.5 billion, the company said late Thursday in a statement. Analysts were looking for $72.2 billion on average, according to data compiled by …read more […]

No Picture
Trading Ideas

3 “Strong Buy” Energy Stocks to Catch on Oil Demand Growth

Oil may be a necessity in today’s economy, but that doesn’t mean oil prices always go up. In recent years, supply has outpaced demand, putting downward pressure on prices. The fracking revolution in the US oil industry, which opened up previously non-viable or unavailable reserves in shale formations, has turned the US into the world’s largest oil producer and, for now, a net exporter of crude oil products.The effect on prices has been long-term macro-level volatility. Prices troughed four years ago, in January 2016, climbed steadily to peak in September 2018, and have been unable to regain highs since, in …read more […]

No Picture
Business News

Bank regulator charges ex-Wells Fargo executives for role in sales scandal

Wells Fargo & Co’s regulator on Thursday announced it had brought civil charges against eight former executives, including former Chief Executive Officer John Stumpf, marking the first federal action against individuals for their role in the bank’s three-year sales practices scandal.

…read more […]

No Picture
Trading Ideas

Gilead assessing Ebola drug as possible coronavirus treatment

Gilead Sciences Inc said on Thursday it was assessing whether its experimental Ebola treatment could be used to treat coronavirus infection. “Gilead is in active discussions with researchers and clinicians in the United States and China regarding the ongoing Wuhan coronavirus outbreak and the potential use of remdesivir as an investigational treatment,” a company spokesman said in an emailed statement. …read more […]